Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -15,440.251 | -13,254.849 | -13,040.348 | -14,810.44 |
| Debt to Asset Ratio | 29.57 | 29.661 | 28.297 | 26.782 |
| Cash Ratio | 106.986 | 158.972 | 118.792 | 165.215 |
| Quick Ratio | 964.677 | 792.732 | 819.021 | 892.36 |
| Current Ratio | 964.677 | 792.732 | 819.021 | 892.36 |